[References]
Uncategorized References
1. Smith JR, Boyle DC, Corless DJ, et al. Abdominal radical
trachelectomy: a new surgical technique for the conservative management
of cervical carcinoma. Br J Obstet Gynaecol. 1997;104:1196-200.
2. Yagi A, Ueda Y, Kakuda M, et al. Epidemiologic and clinical analysis
of cervical cancer using data from the population-based Osaka Cancer
Registry. Cancer Res. 2019;79:1252-9.
3. Willows K, Lennox G, Covens A. Fertility-sparing management in
cervical cancer: balancing oncologic outcomes with reproductive success.Gynecol Oncol Res Pract. 2016;3:9.
4. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA
Cancer J Clin. 2017;67:7-30.
5. Wethington SL, Cibula D, Duska LR, et al. An international series on
abdominal radical trachelectomy: 101 patients and 28 pregnancies.Int J Gynecol Cancer. 2012;22:1251-7.
6. Pareja R, Rendón GJ, Sanz-Lomana CM, Monzón O, Ramirez PT. Surgical,
oncological, and obstetrical outcomes after abdominal radical
trachelectomy - a systematic literature review. Gynecol Oncol.2013;131:77-82.
7. Kasuga Y, Nishio H, Miyakoshi K, et al. Pregnancy outcomes after
abdominal radical trachelectomy for early-stage cervical cancer: a
13-year experience in a single tertiary-care center. Int J Gynecol
Cancer. 2016;26:163-8.
8. Shah JS, Jooya ND, Woodard TL, Ramirez PT, Fleming ND, Frumovitz M.
Reproductive counseling and pregnancy outcomes after radical
trachelectomy for early stage cervical cancer. J Gynecol Oncol.2019;30:e45.
9. Li X, Xia L, Li J, Chen X, Ju X, Wu X. Reproductive and obstetric
outcomes after abdominal radical trachelectomy (ART) for patients with
early-stage cervical cancers in Fudan, China. Gynecol Oncol.2020;157:418-22.
10. Tamauchi S, Kajiyama H, Sakata J, et al. Oncologic and obstetric
outcomes of early stage cervical cancer with abdominal radical
trachelectomy: single-institution experience. J Obstet Gynaecol
Res. 2016;42:1796-801.
11. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm
delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med.2003;348:2379-85.
12. Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal
administration of progesterone for preventing preterm birth in women
considered to be at risk of preterm birth. Cochrane Database Syst
Rev. 2013:CD004947.
13. Romero R, Conde-Agudelo A, Da Fonseca E, et al. Vaginal progesterone
for preventing preterm birth and adverse perinatal outcomes in singleton
gestations with a short cervix: a meta-analysis of individual patient
data. Am J Obstet Gynecol. 2018;218:161-80.
14. O’Brien JM, Lewis DF. Prevention of preterm birth with vaginal
progesterone or 17-alpha-hydroxyprogesterone caproate: a critical
examination of efficacy and safety. Am J Obstet Gynecol.2016;214:45-56.
15. Iams JD, Berghella V. Care for women with prior preterm birth.Am J Obstet Gynecol. 2010;203:89-100.
16. Norman JE. Progesterone and preterm birth. Int J Gynecol
Obstet. 2020;150:24-30.
17. Society for Maternal-Fetal Medicine Publications Committee, with
assistance of Vincenzo Berghella. Progesterone and preterm birth
prevention: translating clinical trials data into clinical practice.Am J Obstet Gynecol. 2012;206:376-86.
18. Okugawa K, Kobayashi H, Sonoda K, et al. Oncologic and obstetric
outcomes and complications during pregnancy after fertility-sparing
abdominal trachelectomy for cervical cancer: a retrospective review.Int J Clin Oncol. 2017;22:340-6.
19. Ebisawa K, Takano M, Fukuda M, et al. Obstetric outcomes of patients
undergoing total laparoscopic radical trachelectomy for early stage
cervical cancer. Gynecol Oncol. 2013;131:83-6.
20. Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone
reduces the rate of preterm birth in women with a sonographic short
cervix: a multicenter, randomized, double-blind, placebo-controlled
trial. Ultrasound Obstet Gynecol. 2011;38:18-31.
21. Society for Maternal Fetal Medicine Publications Committee. ACOG
Committee Opinion number 419 October 2008 (replaces no. 291, November
2003). Use of progesterone to reduce preterm birth. Obstet
Gynecol. 2008;112:963-5.
22. Winer N, Bretelle F, Senat MV, et al. 17 alpha-hydroxyprogesterone
caproate does not prolong pregnancy or reduce the rate of preterm birth
in women at high risk for preterm delivery and a short cervix: a
randomized controlled trial. Am J Obstet Gynecol.2015;212:485.e1-10.
23. Maher MA, Abdelaziz A, Ellaithy M, Bazeed MF. Prevention of preterm
birth: a randomized trial of vaginal compared with intramuscular
progesterone. Acta Obstet Gynecol Scand. 2013;92:215-22.
24. Jain V, McDonald SD, Mundle WR, Farine D. Guideline No. 398:
progesterone for prevention of spontaneous preterm birth. J
Obstetr Gynaecol Can. 2020;42:806-12.